Cardinal Health, Inc.
https://www.cardinalhealth.com/en.html
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cardinal Health, Inc.
Aldeyra All Set For Double Date With The FDA
The US agency is reviewing two of the US biotech’s drug with decisions expected on its methotrexate product for ocular lymphoma by June and on the dry eye drug reproxalap in November, as Aldeyra mulls its marketing strategy for both.
FY2022: Medtech Innovators Exchange Top 10 Placings
The leading global medtechs’ fiscal 2022 revenue reports are all in: Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished the year with strong quarters and Roche dropped a few places.
Keeping Track: Opdivo, Keytruda Continue Adjuvant Push As Cancer Dominates Recent Applications
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Global Top 10 Medtechs Swap Places After Latest Quarterlies
Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Distributors
- Medical Devices
- Services
-
Services
- Home Infusion
- Hospitals, Nursing Homes, Institutions
- Pharmacy Services, PBMs
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
- Other Names / Subsidiaries
-
- AccessClosure
- Allegiance Healthcare Corporation
- Cordis Corporation
- Innovative Therapies, naviHealth
- OutcomesMTM
- The Harvard Drug Group
- VIASYS Healthcare
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice